Proactive Investors - Run By Investors For Investors

Chemistree to raise up to C$8.2M for growth in Washington State, California

In addition to the convertible debenture offering, the cannabis investment company intends to raise as much as C$1.4 million in a non-brokered private placement basis
Chemistree logos
The cannabis investment company plans to use proceeds for growth in Washington State and California

Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) said it has filed a final short-form prospectus on its previously announced offering of 8,200 convertible debenture units for aggregate proceeds of as much as C$8.2 million to support growth in Washington State and California.

In addition, the cannabis investment company said late Monday it intends to issue up to 1,400 debenture units on a non-brokered private placement basis for aggregate gross proceeds of up to C$1.4  million.

Vancouver-based Chemistree plans to use the net proceeds of the offering and the private placement to expand its facilities in Washington State; expand its brands in California, including the launch of Sugarleaf products; and continue the licensing, development and ultimately the buildout of the Chemistree’s property in Desert Hot Springs, California.

READ: Chemistree granted conditional use permit for Desert Hot Springs land

The proceeds will also be used for working capital and general corporate purposes.

The offerings will not be registered under the US Securities Act of 1933 or any US state securities laws, according to Chemistree.

Shares of Chemistree climbed C$0.01 to C$0.48 in Monday’s Canadian trading. They were up US$0.01 to US$0.35 on the OTC Markets.

Last month, the company said its subsidiary CHM Desert LLC had won a conditional use permit from local authorities in Desert Hot Springs, California for its 9.55-acre property in the city’s cannabis cultivation-friendly zone.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
cannabis facility
January 23 2019
The company will capitalize on the need for indoor-grown, pharmaceutical-grade cannabis
A cannabis plant shown next to an oil-based product
April 23 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use